SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm
Monday, January 23, 2023 1 min read
Key Takeaway: PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit”) on behalf of the Company’s investors.
The investigation seeks to determine whether Summit issued false and misleading statements
Market Sentiment Analysis
CONCERNS & RISKS
The investigation suggests potential false and misleading statements by Summit.
Concerns over Summit's compliance with securities laws could harm investor confidence.
Shareholders may have suffered financial harm due to the lack of material disclosures.
Full Press Release Details
PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit”) on behalf of the Company’s investors.
The investigation seeks to determine whether Summit issued false and misleading statements and/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company’s shareholders.
Summit shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/summit-therapeutics/, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
D. Seamus Kaskela, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
Tags
Frequently Asked Questions
What is Kaskela Law investigating regarding Summit Therapeutics?
Kaskela Law is investigating potential false statements and failures to disclose facts by Summit Therapeutics.
Why are Summit Therapeutics shareholders encouraged to contact Kaskela Law?
Shareholders are urged to contact Kaskela Law to learn about their legal rights and options.
What type of litigation does Kaskela Law specialize in?
Kaskela Law specializes in securities fraud, corporate governance, and merger litigation.
Where can investors find more information on this investigation?
Investors can visit Kaskela Law's website for more details on the investigation.
How can I contact Kaskela Law for information?
You can contact Kaskela Law by phone at (484) 229-0750 or via email.